SELUMENTINIB FOR THE PREVENTION OF PLEXIFORM NEUROFIBROMA GROWTH AND MORBIDITY IN YOUNG CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1)
$1,181,297FY2021Defense Health AgencyDOD
University Of Alabama At Birmingham, Birmingham AL
University Of Alabama At Birmingham, Birmingham AL